EXCLUSIVE: Pasithea Therapeutics’ Wholly Owned Subsidiary Pasithea Clinics To Launch In-Home Intravenous Ketamine Therapy In New York City, Los Angeles, San Diego, And San Francisco To Expand Its International Footprint
Miami Beach, FL / November 17, 2021 -- Pasithea Therapeutics Corp. (Nasdaq:
KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused
on the research and discovery of new and
